Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

Fig. 3

Kaplan–Meier survival curves representing the estimated cumulative incidence of all-caused death (a), non-fatal MI (b), revascularization (c), stroke (d), and GI bleeding (e) after 18 months in sustained, intermittent users and non-users groups. GI, gastrointestinal; MI, myocardial infarction; PPI, proton pump inhibitor

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us